The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age

NCT03114982 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Varicella

Interventions

BIOLOGICAL: NBP608
BIOLOGICAL: Varivax

Sponsor

SK Chemicals Co., Ltd.